Vol 8, No 5 (October 29, 2018): Cardiovascular Diagnosis and Therapy (Platelet Function and Antiplatelet Therapy)

Review Article

Interaction between platelets and endothelium: from pathophysiology to new therapeutic options
Michalis Hamilos, Stylianos Petousis, Fragiskos Parthenakis
Tissue factor: newer concepts in thrombosis and its role beyond thrombosis and hemostasis
Giovanni Cimmino, Plinio Cirillo
Diabetes and antiplatelet therapy: from bench to bedside
Jose R. Rivas Rios, Francesco Franchi, Fabiana Rollini, Dominick J. Angiolillo
Impact of genetic polymorphisms on platelet function and response to anti platelet drugs
Teresa Strisciuglio, Danilo Franco, Giuseppe Di Gioia, Chiara De Biase, Carmine Morisco, Bruno Trimarco, Emanuele Barbato
Monitoring platelet function: what have we learned from randomized clinical trials?
Pierre Deharo, Thomas Cuisset
The optimal duration of dual antiplatelet therapy after coronary stent implantation: to go too far is as bad as to fall short
Francesco Costa, Marco Valgimigli
Antiplatelet agents in uncertain clinical scenarios—a bleeding nightmare
Sean Esmonde, Divyesh Sharma, Aaron Peace
Antiplatelet therapy for peripheral artery disease
Rosetta Melfi, Elisabetta Ricottini
Antiplatelet therapy in valvular and structural heart disease interventions
Annunziata Nusca, Edoardo Bressi, Iginio Colaiori, Marco Miglionico, Germano Di Sciascio

Disclosure:

The focused issue “Platelet Function and Antiplatelet Therapy” was commissioned by the editorial office, Cardiovascular Diagnosis and Therapy without any sponsorship or funding. Fabio Mangiacapra and Emanuele Barbato served as the unpaid Guest Editors for the focused issue.